Trademark: CAR T TOGETHER 2382703
Word
CAR T TOGETHER
ID
2382703
Trademark Type
Word
Status
Published: Awaiting indexing
Application Date
02 February 2023
Owner(s)
Service
Goods and Services:
Class 16:
Printed publications, namely, pamphlets and brochures about research, detection, diagnosis, and medical treatments in the fields of pharmaceuticals, cell therapies, chimeric antigen receptor T cell therapy, oncology, and cancer.
Printed publications, namely, pamphlets and brochures about research, detection, diagnosis, and medical treatments in the fields of pharmaceuticals, cell therapies, chimeric antigen receptor T cell therapy, oncology, and cancer.
Class 35:
Promoting public awareness about cancer (term considered too vague by the International Bureau - Rule 13 (2) (b) of the Regulations); promoting public awareness about chimeric antigen receptor T cell therapy (term considered too vague by the International Bureau - Rule 13 (2) (b) of the Regulations); promoting public awareness about research, detection, diagnosis, and medical treatments in the fields of pharmaceuticals, cell therapies, chimeric antigen receptor T cell therapy, oncology, and cancer (term considered too vague by the International Bureau - Rule 13 (2) (b) of the Regulations).
Promoting public awareness about cancer (term considered too vague by the International Bureau - Rule 13 (2) (b) of the Regulations); promoting public awareness about chimeric antigen receptor T cell therapy (term considered too vague by the International Bureau - Rule 13 (2) (b) of the Regulations); promoting public awareness about research, detection, diagnosis, and medical treatments in the fields of pharmaceuticals, cell therapies, chimeric antigen receptor T cell therapy, oncology, and cancer (term considered too vague by the International Bureau - Rule 13 (2) (b) of the Regulations).
Class 41:
Providing online non-downloadable publications in the nature of pamphlets, reports, articles, and brochures featuring information about research, detection, diagnosis, and medical treatments in the fields of cancer, immunotherapy, pharmaceuticals, oncology, cell therapies, and chimeric antigen receptor T cell therapy; on-line publication of electronic journals in the nature of blogs, featuring information about research, detection, diagnosis, and medical treatments in the fields of cancer, immunotherapy, pharmaceuticals, oncology, cell therapies, and chimeric antigen receptor T cell therapy.
Providing online non-downloadable publications in the nature of pamphlets, reports, articles, and brochures featuring information about research, detection, diagnosis, and medical treatments in the fields of cancer, immunotherapy, pharmaceuticals, oncology, cell therapies, and chimeric antigen receptor T cell therapy; on-line publication of electronic journals in the nature of blogs, featuring information about research, detection, diagnosis, and medical treatments in the fields of cancer, immunotherapy, pharmaceuticals, oncology, cell therapies, and chimeric antigen receptor T cell therapy.
Class 42:
Providing information about medical research in the field of cancer; providing information about medical research in the field of chimeric antigen receptor T cell therapy; medical and scientific research in the field of cancer treatment and chimeric antigen receptor T cell therapy.
Providing information about medical research in the field of cancer; providing information about medical research in the field of chimeric antigen receptor T cell therapy; medical and scientific research in the field of cancer treatment and chimeric antigen receptor T cell therapy.
Class 44:
Providing medical information in the field of cancer; providing medical information in the field of chimeric antigen receptor T cell therapy; providing medical information in the form of reports in the field of immunotherapy and cancer treatment; providing medical information about research, detection, diagnosis, and medical treatments in the fields of cancer, immunotherapy, pharmaceuticals, oncology, cell therapies, and chimeric antigen receptor T cell therapy via a website; providing medical information about research, detection, diagnosis, and medical treatments in the fields of cancer, immunotherapy, pharmaceuticals, oncology, cell therapies, and chimeric antigen receptor T cell therapy via an internet website portal.
Providing medical information in the field of cancer; providing medical information in the field of chimeric antigen receptor T cell therapy; providing medical information in the form of reports in the field of immunotherapy and cancer treatment; providing medical information about research, detection, diagnosis, and medical treatments in the fields of cancer, immunotherapy, pharmaceuticals, oncology, cell therapies, and chimeric antigen receptor T cell therapy via a website; providing medical information about research, detection, diagnosis, and medical treatments in the fields of cancer, immunotherapy, pharmaceuticals, oncology, cell therapies, and chimeric antigen receptor T cell therapy via an internet website portal.